Literature DB >> 29570919

De novo CMV-associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient.

Anup M Patel1, Robert D Zenenberg2, Ryan J Goldberg1.   

Abstract

Collapsing focal segmental glomerulosclerosis (FSGS) is a variant of FSGS and is associated with severe nephrotic syndrome and acute kidney injury and can occur after kidney transplantation. The exact mechanism of collapsing FSGS after kidney transplantation is unknown, but potential causes include autoimmune diseases, certain malignancies, bisphosphonates, m-TOR inhibitors, interferon-alpha, HIV infection, and other viruses. We describe a case of de novo Cytomegalovirus (CMV)-associated collapsing FSGS in a kidney transplant recipient with a UL97 phosphotransferase mutation that was successfully treated with intravenous ganciclovir, intravenous immunoglobulin, and steroids.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990CMVzzm321990; collapsing FSGS; kidney transplant

Mesh:

Substances:

Year:  2018        PMID: 29570919     DOI: 10.1111/tid.12884

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2018-12       Impact factor: 10.612

Review 2.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

Review 3.  Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review.

Authors:  Haiting Lin; Lizhi Chen; Songyang Wen; Zhihui Yue; Ying Mo; Xiaoyun Jiang; Liuyi Huang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.